TREM1 and glioblastoma: After differential genes were identified, gene set enrichment analysis demonstrated that the triggering receptor expressed on myeloid cells 1 (TREM1) signaling pathway was significantly different between macrophages associated with primary and recurrent glioblastoma (Figure 3D, false-discovery rate (FDR) < 0.001).